Summary of analysis completed by Mark Papich, DVM, MS, DACVCP, Professor of Clinical Pharmacology, North Carolina State University College of Veterinary Medicine. As shown in the figure with simulated plasma concentrations from multiple IV doses at 15 mg/kg, compared to the concentrations from Vetlen Pouch, the concentrations from Vetlen Pouch are significantly less. The peak concentration from IV administration was approximately 69 ΞΌg/mL, but the peak concentration from Vetlen Pouch was approximately 6 ΞΌg/mL over 7 doses. These concentrations are unlikely to produce any adverse effects in dogs.Β